Global AI in Fitness and Wellness Market Size was valued at USD 10.68 Billion in 2025 and is predicted to reach USD 57.80 Billion by the year 2035 at a 19.3% CAGR during the forecast period for 2026 ...
Positioned to Lead with AI-Driven Production Technology LAS VEGAS, NV / ACCESS Newswire / April 27, 2026 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology innovator focused on scalable production of ...
ESTERO, FL / ACCESS Newswire / April 27, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug ...
MISSISSAUGA, ON / ACCESS Newswire / April 27, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that one of its ...
Oversubscribed round backed by existing shareholdersInvestment will support development of cardiovascular disease database to ...
The Best Thigh Lift Is Done by Dr. Alberico Sessa in Florida SARASOTA, FL / ACCESS Newswire / April 27, 2026 / Interest in body contouring continues to rise as patients are actively looking for ...
LUND, SE / ACCESS Newswire / April 27, 2026 / Cantargia AB (Nasdaq Stockholm:CANTA), a clinical-stage biotechnology company focused on antibody-based therapeutics targeting IL1RAP, today announced ...
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained ...
PharmaNest, a leader in high-resolution single-fiber digital pathology and AI, will present five communications at Digestive Disease Week (DDW) 2026, showcasing its advanced technologies for the study ...
Paying Patients to Access the Nation’s #1 Prescribed Oral Blood ThinnerPRINCETON, N.J.--(BUSINESS WIRE)--$BMY #Eliquis--The Bristol Myers Squibb-Pfizer (BMS NYSE: BMY) — (Pfizer NYSE: PFE) Alliance ...
Nantes, France, April 23, 2026 – 7:30am CEST - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage biotech company dedicated to developing first-in-class therapies in ...
MMJ International Holdings, an FDA IND-stage pharmaceutical cannabinoid developer, is a plaintiff in landmark litigation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results